Search

everythinglearnresearchcommunity

for

Search:↓

Blocking YAP/TAZ could be a new way to treat skin cancer.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Engineered extracellular vesicles can improve tissue repair and regeneration.

Understanding EGFR roles could lead to new hair loss treatments.

Testosterone reduces knee flexibility by affecting relaxin receptors.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Overactive Wnt signaling in mouse skin stem cells causes acne-like cysts and shrinking oil glands, which some treatments can partially fix.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

New technologies show promise for better hair regeneration and treatments.

The formulation with oleic acid may be better for treating male pattern baldness.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.